|
1. Sharma L. Osteoarthritis of the knee. N Engl J Med 2021;384:51-9. doi: 10.1056/NEJMcp1903768. 2. Allen KD, Thoma LM, Golightly YM. Epidemiology of osteoarthritis. Osteoarthritis Cartilage 2022;30:184-95. doi: 10.1016/j.joca.2021.04.020. 3. . Lefèvre S, Knedla A, Tennie C, Kampmann A, Wunrau C, Dinser R, et al. Synovial fibroblasts spread rheumatoid arthritis to unaffected joints. Nat Med 2009;15:1414-20. doi: 10.1038/nm.2050. 4. Xu Q, Gai PY, Lv HL, Li GR, Liu XY. Association of MMP3 genotype with susceptibility to frozen shoulder: a case-control study in a Chinese Han population. Genet Mol Res 2016;15:10-4238. doi: 10.4238/gmr.15017228. 5. Huang X, You Y, Xi Y, Ni B, Chu X, Zhang R, et al. p-Coumaric acid attenuates IL-1β-induced inflammatory responses and cellular senescence in rat chondrocytes. Inflammation 2020;43:619-28. doi: 10.1007/s10753-019-01142-7. 6. Gao JW, Zhang KF, Lu JS, Su T. Serum matrix metalloproteinases-3 levels in patients with ankylosing spondylitis. Genet Mol Res 2015;14:17068-78. doi: 10.4238/2015.December.16.7. 7. Milaras C, Lepetsos P, Dafou D, Potoupnis M, Tsiridis E. Association of matrix metalloproteinase (MMP) gene polymorphisms with knee osteoarthritis: a review of the literature. Cureus 2021;13. doi: 10.7759/cureus.18607. 8. Keller LE, Wojno ED, Begum L, Fortier LA. Regulatory T cells provide chondroprotection through increased TIMP1, IL-10 and IL-4, but cannot mitigate the catabolic effects of IL-1β and IL-6 in a tri-culture model of osteoarthritis. Osteoarthr Cartil Open 2021;3:100193. doi: 10.1016/j.ocarto.2021.100193. 9. Ma JD, Zhou JJ, Zheng DH, Chen LF, Mo YQ, Wei XN, et al. Serum matrix metalloproteinase-3 as a noninvasive biomarker of histological synovitis for diagnosis of rheumatoid arthritis. Mediators Inflamm 2014;2014 :179284. doi: 10.1155/2014/179284. 10. Yang S, Ryu JH, Oh H, Jeon J, Kwak JS, Kim JH, et al. NAMPT (visfatin), a direct target of hypoxia-inducible factor-2α, is an essential catabolic regulator of osteoarthritis. Ann Rheum Dis 2015;74:595-602. doi: 10.1136/annrheumdis-2013-204355. 11. Grässel S, Muschter D. Recent advances in the treatment of osteoarthritis. F1000Res 2020;9. doi: 10.12688/f1000research.22115.1. 12. Momtaz S, Abdollahi M. An Update on Pharmacology of Satureja Species; From Antioxidant, Antimicrobial, Antidiabetic and Anti-hyperlipidemic to Reproductive Stimulation. Int J Pharmacol 2010; 6:346-353. doi: 10.3923/ijp.2010.346.353. 13. Maghsoudi H, Hallajzadeh J, Rezaeipour M. Evaluation of the effect of polyphenol of escin compared with ibuprofen and dexamethasone in synoviocyte model for osteoarthritis: an in vitro study. Clin Rheumato 2018;37:2471-8. doi: 10.1007/s10067-018-4097-z. 14. Jeong YH, Oh YC, Cho WK, Shin H, Lee KY, Ma JY. Anti-inflammatory effects of Viola yedoensis and the application of cell extraction methods for investigating bioactive constituents in macrophages. BMC Complement Altern Med 2016;16:1-6. doi: 10.1186/s12906-016-1142-9. 15. Padumadasa C, Dharmadana D, Abeysekera A, Thammitiyagodage M. In vitro antioxidant, anti-inflammatory and anticancer activities of ethyl acetate soluble proanthocyanidins of the inflorescence of Cocos nucifera L. BMC Complement Altern Med 2016;16:1-6. doi:10.1186/s12906-016-1335-2 16. Eriksson JE, Dechat T, Grin B, Helfand B, Mendez M, Pallari HM, et al. Introducing intermediate filaments: from discovery to disease. J Clin Invest 2009;119:1763-71. doi: 10.1172/JCI38339. 17. Garbison KE, Heinz BA, Lajiness ME, Weidner JR, Sittampalam GS, Lajiness ME, et al. Assay Guidance Manual. Eli Lilly & Company and the National Center for Advancing Translational Sciences. 2004. 18. Indrayanto G, Putra GS, Suhud F. Validation of in-vitro bioassay methods: Application in herbal drug research. Profiles Drug Subst Excip Relat Methodol 2021;46:273-307. doi: 10.1016/bs.podrm.2020.07.005. 19. Liao HY, Da CM, Liao B, Zhang HH. Roles of matrix metalloproteinase-7 (MMP-7) in cancer. Clin Biochem 2021;92:9-18. doi: 10.1016/j.clinbiochem.2021.03.003. 20. Freitas-Rodriguez S, Folgueras AR, Lopez-Otin C. The role of matrix metalloproteinases in aging: Tissue remodeling and beyond. Biochim Biophys Acta Mol Cell Res 2017;1864:2015-25. doi: 10.1016/j.bbamcr.2017.05.007. 21. McCabe MC, Hill RC, Calderone K, Cui Y, Yan Y, Quan T, et al. Alterations in extracellular matrix composition during aging and photoaging of the skin. Matrix Biol Plus 2020;8:100041. doi: 10.1016/j.mbplus.2020.100041. 22. Mehana ES, Khafaga AF, El-Blehi SS. The role of matrix metalloproteinases in osteoarthritis pathogenesis: An updated review. Life Sci 2019;234:116786. doi: 10.1016/j.lfs.2019.116786. 23. Latourte A, Kloppenburg M, Richette P. Emerging pharmaceutical therapies for osteoarthritis. Nat Rev Rheumatol 2020;16:673-88. doi: 10.1038/s41584-020-00518-6. 24. Lee AS, Ellman MB, Yan D, Kroin JS, Cole BJ, van Wijnen AJ, et al. A current review of molecular mechanisms regarding osteoarthritis and pain. Gene 2013;527(2):440-7. doi: 10.1016/j.gene.2013.05.069. 25. Blasioli DJ, Kaplan DL. The roles of catabolic factors in the development of osteoarthritis. Tissue Eng Part B Rev 2014;20:355-63. doi: 10.1089/ten.TEB.2013.0377. 26. Sirikaew N, Chomdej S, Tangyuenyong S, Tangjitjaroen W, Somgird C, Thitaram C, et al. Proinflammatory cytokines and lipopolysaccharides up regulate MMP-3 and MMP-13 production in Asian elephant (Elephas maximus) chondrocytes: Attenuation by anti-arthritic agents. BMC Vet Res 2019;15:1-3. doi: 10.1186/s12917-019-2170-8. 27. Rose BJ, Kooyman DL. A tale of two joints: the role of matrix metalloproteases in cartilage biology. Dis Markers 2016;2016. doi: 10.1155/2016/4895050. 28. Malemud CJ. Matrix metalloproteinases and synovial joint pathology. Prog Mol Biol Transl Sci 2017;148:305-25. doi: 10.1016/bs.pmbts.2017.03.003. 29. Li G, Liu D, Zhang Y, Qian Y, Zhang H, Guo S, et al. Celastrol inhibits lipopolysaccharide-stimulated rheumatoid fibroblast-like synoviocyte invasion through suppression of TLR4/NF-κB-mediated matrix metalloproteinase-9 expression. PloS One 2013;8:e68905. doi: 10.1371/journal.pone.0068905. 30. Hu Q, Ecker M. Overview of MMP-13 as a Promising Target for the Treatment of Osteoarthritis. Int J Mol Sci 2021;22:1742. doi: 10.3390/ijms22041742. 31. Wan Y, Li W, Liao Z, Yan M, Chen X, Tang Z. Selective MMP-13 inhibitors: promising agents for the therapy of Osteoarthritis. Curr Med Chem 2020;27:3753-69. doi: 10.2174/0929867326666181217153118. 32. Nakabayashi H, Shimizu K. HA1077, a Rho kinase inhibitor, suppresses glioma‐induced angiogenesis by targeting the Rho‐ROCK and the mitogen‐activated protein kinase kinase/extracellular signal‐regulated kinase (MEK/ERK) signal pathways. Cancer Sci 2011;102:393-9. doi: 10.1111/j.1349-7006.2010.01794.x.
|
